Status:
COMPLETED
Mederma to Reduce Appearance of Post Surgical Scars
Lead Sponsor:
Merz North America, Inc.
Conditions:
Scars
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This is a single-center, 20-subject, investigator-blinded study to evaluate the effect of Mederma N\&I to Mederma Ultra Gel on the appearance of post-surgical scars.
Detailed Description
This is a 10-week research study designed to compare the effect of two gels on the appearance of post surgical scarring of the chest and/or back. The subject will be asked to identify two symmetrical ...
Eligibility Criteria
Inclusion
- Subjects must be 18-70 years of age, of any race or sex.
- Subjects must be Fitzpatrick skin type I-VI.
- Subjects must have two symmetrical upper chest and/or back seborrheic keratoses and in the opinion of the investigator are good candidates for the study.
Exclusion
- Subjects with known allergies or sensitivities to ingredients contained in the test product including onion extract and Lidocaine.
- Subjects with known history of keloids or hypertrophic scars.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01504061
Start Date
January 1 2012
End Date
August 1 2012
Last Update
October 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology, Laser, and Vein Specialists of the Carolinas, PLLC
Charlotte, North Carolina, United States, 28207